Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-05

Clinical Trial Update: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating efficacy and safety of drugs for visceral leishmaniasis in Brazil was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Brasilia | Conditions: Visceral Leishmaniasis | Phase 4 | Status: TERMINATED